Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Phase of Trial: Phase I/II
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Everolimus (Primary) ; Lonafarnib (Primary)
- Indications Progeria
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 26 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 23 Oct 2015 New trial record